A rigorous review of Tesamorelin peptide research, highlighting its GHRH analogue mechanism, phase 3 human clinical trial data on visceral adiposity and he
Read more Tesamorelin Peptide Review: Mechanism, Evidence, and Clinical Research
A rigorous review of Tesamorelin peptide research, highlighting its GHRH analogue mechanism, phase 3 human clinical trial data on visceral adiposity and he
Read more Tesamorelin Peptide Review: Mechanism, Evidence, and Clinical Research
A Minto Pyramid analysis of Sermorelin (GHRH 1-29 acetate), outlining its molecular pharmacology, human clinical trial evidence, and downstream metabolic a
Read more Sermorelin (GHRH 1-29): Mechanisms, Clinical Evidence, and Research Applications
A rigorous scientific breakdown of Ipamorelin, outlining its mechanism as a selective GHS-R1a agonist, preclinical and clinical trial data, and distinct en
Read more Ipamorelin Research Peptide: Mechanism, Selectivity, and Clinical Evidence
A structured Minto Pyramid analysis of glutathione as a research peptide, detailing its role in intracellular redox homeostasis, Phase II detoxification, a
Read more Glutathione as a Research Peptide: Cellular Redox, Detoxification, and Clinical Evidence
A scientific analysis of the heptapeptide Selank, evaluating its GABAergic anxiolysis, BDNF-mediated cognitive enhancement, and immunomodulatory activity a
Read more Selank Peptide: Mechanisms, Cognitive Effects, and Clinical Evidence
PE-22-28 is a synthetic, shortened derivative of spadin that selectively inhibits TREK-1 potassium channels, showing rapid-onset neurogenic and antidepress
Read more PE-22-28 Research Peptide: Mechanism, TREK-1 Blockade, and Preclinical Evidence
A comprehensive, evidence-tiered analysis of Adamax peptide—evaluating its adamantane-modified Semax structure, proposed neurotrophic mechanisms, and curre
Read more Adamax Peptide: Neurotrophic Mechanisms, Pharmacology, and Scientific Evidence